STOCK TITAN

LiqTech International, Inc. 10-Q Filings

LIQT NASDAQ

Every 10-Q that LiqTech International, Inc. (LIQT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow LIQT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LIQT filings page.

Rhea-AI Summary

LiqTech International, Inc. reported lower revenue and wider losses for the three and six months ended June 30, 2026, while significantly strengthening its balance sheet through equity financing and debt repayment. Q2 2026 revenue was $4.36M, down 12.0% from $4.96M a year earlier, mainly due to non-recurring 2025 system sales, while the six-month revenue was $8.50M, down 11.2% from $9.58M.

Q2 gross margin was 8.4%, and the six-month gross margin improved to 8.9% from 6.4% in 2025, but operating expenses rose and other expenses increased sharply from higher interest, debt discount amortization, and FX losses. Net loss grew to $3.05M in Q2 and $5.78M for six months, up 41.2% and 27.8% year over year, respectively.

Liquidity improved markedly: cash increased to $15.66M and working capital to $21.37M, driven by a 20,000,000-share public offering at $1.00 per share and issuance of 3,000,000 shares to cancel $3.0M of senior promissory notes, with the remaining $3.0M repaid in cash. Total liabilities fell to $12.15M, and equity rose to $25.80M. Management expects existing cash and operations to fund the next 12 months but notes macroeconomic uncertainty and continued material weaknesses in internal control over financial reporting.

Rhea-AI Summary

LiqTech International, Inc. reported a net loss of $2.7M for the quarter ended March 31, 2026, compared with a $2.4M loss a year earlier, as revenue declined and operating costs rose. Revenue fell 10.4% to $4.1M, mainly due to non‑recurring prior-year system sales, partly offset by stronger Filters, Membranes, and Components volumes and higher Pool and Marine system sales.

Gross profit improved to $0.4M, a 9.5% margin, from $0.1M or 2.7%, helped by mix, better factory utilization and procurement. However, operating expenses increased 15.6% to $2.7M, driven by selling investments, foreign exchange effects and higher R&D. Other expenses rose to $0.45M, mainly from foreign currency losses and interest on senior promissory notes.

The company ended the quarter with cash and restricted cash of $2.7M, net working capital of $8.5M, total assets of $24.9M, and total liabilities of $17.4M. Management states that recent operating losses and cash usage raise substantial doubt about LiqTech’s ability to continue as a going concern over the next twelve months and is pursuing cost optimization, operational initiatives and potential debt or equity financing to improve liquidity.

Rhea-AI Summary

LiqTech International (LIQT) filed its Q3 2025 10‑Q, showing stronger top-line performance and improved margins. Revenue rose to $3,807,274 (up 53.6% year over year), and gross margin turned positive at 19.6%, driven by pool system deliveries, aftermarket sales, and plastics, partially offset by lower DPF shipments.

The quarterly net loss narrowed to $1,459,762. For the first nine months, revenue reached $13,382,304 with gross profit improving versus last year. Cash was $7,354,024 and net working capital was $13,406,883. Total liabilities were $17,519,010 and equity $12,776,858.

The company highlighted a March 2025 amendment to its senior notes: maturity extended to May 1, 2027, and interest at 10% per annum begins January 1, 2026; related warrants were repriced to $2.00 and extended to December 31, 2029. A 90%-owned China JV received RMB 8,000,000 partner funding as a 12% loan to support marine water treatment. As of November 14, 2025, common shares outstanding were 9,627,064. Management reported disclosure controls were not effective due to ongoing material weaknesses, with remediation efforts continuing.

Rhea-AI Summary

LiqTech International reported revenue of $4.96 million for the quarter (up 10.5% year-over-year) and $9.58 million for the six months (up 9.8%). Gross margins contracted to 9.8% in the quarter from 16.0% a year earlier and to 6.4% for the six months from 11.3%, driven by underutilized manufacturing after a decline in DPF sales, provisions for slow-moving inventory and development costs on a first full-scale PureFlow delivery.

The company recorded a net loss of $2.16 million for the quarter and $4.52 million for the six months, with basic and diluted loss per share of $0.22 and $0.47, respectively. Cash on hand was $8.67 million and net working capital was $14.31 million at June 30, 2025. Management states the cash balance and ongoing operations are expected to be sufficient to cover capital requirements for the next 12 months. The company formed a 90% joint venture in China that received RMB 8.0 million (~$1.1M) in R&D funding structured as a long-term loan, and disclosed material weaknesses in internal controls over financial reporting.